151. Genomic aberrations affecting the outcome of immunodeficiency-related diffuse large B-cell lymphoma.
- Author
-
Kwee, Ivo, Capello, Daniela, Rinaldi, Andrea, Rancoita, Paola M. V., Bhagat, Govind, Greiner, Tim C., Spina, Michele, Gloghini, Annunziata, Chan, Wing C., Paulli, Marco, Zucca, Emanuele, Tirelli, Umberto, Carbone, Antonino, Gaidano, Gianluca, and Bertoni, Francesco
- Subjects
- *
B cell lymphoma , *HIV antibodies , *UNIVARIATE analysis , *IMMUNOCOMPETENT cells , *IMMUNODEFICIENCY , *PATIENTS - Abstract
The objective of this study was to evaluate the prognostic impact of genomic regions in a series of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphomas (HIV-DLBCLs) and post-transplant DLBCLs (PT-DLBCLs) analyzed by genome-wide DNA profiling. Minimal common regions (MCRs) were estimated on genomic profiles obtained using Affymetrix Human Mapping 250k Nsp I arrays and tested for their impact on clinical outcome by univariate analysis on 36 PT-DLBCLs, 19 HIV-DLBCLs and, as a control group, 149 DLBCLs arising in immunocompetent individuals (IC-DLBCLs). PT-DLBCL and HIV-DLBCL presented a similar outcome. Immunodeficiency-related DLBCL (ID-DLBCL) had a worse overall survival (OS) than IC-DLBCL. Seven MCRs showed a statistical impact on OS in PT-DLBCL and four in HIV-DLBCL. Among these, the presence of gains at 1q or at 18q defined a group of patients with PT-DLBCL with a very poor outcome ( p < 0.0001). The presence of del(3p14.2) or of ++ 2p23.1 identified a group of HIV-DLBCLs with a very poor outcome ( p == 0.0072). It was concluded that genomic aberrations affecting outcome differ between ID-DLBCL and IC-DLBCL and are also dependent on the type of acquired immunodeficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2012
- Full Text
- View/download PDF